A year-end look at what actually worked and why. The theme of 2025 in micro-cap investing was straightforward in retrospect: profitability mattered, clean balance sheets mattered, domestic revenue mattered. Pre-revenue names with attractive narratives but no earnings power continued to underperform. The quality divide that began in 2022 extended and deepened through 2025. The Russell Microcap Index gained 19% on the year, but that headline number masked a 40 percentage point spread between the top and bottom quartiles by quality factor. Investors who screened for positive free cash flow and net cash positions captured the index gain plus an additional 8-12 points of alpha on a sector-neutral basis.
The most important lesson from 2025 is one that should not need to be re-learned every cycle but always is: in micro-cap investing, the question is not just whether the business eventually works, but whether the company survives long enough for the business to work. Cash runway, dilution trajectory, and operating leverage are more important than the attractiveness of the long-term vision.